| HOME | THE
YEAR'S HIGHLIGHTS | A record of accomplishment
 
From winning awards and co-ordinating national projects to
building stronger partnerships for commercialization, the
NCE program accomplished much throughout 2004-2005. Here are
a few of the highlights:
March, 2005
Industry Minister David Emerson announces
the investment of up to $55 million over three years to further
the research activities of AUTO21 – The Automobile
of the 21st Century, the Canadian Language
and Literacy Research Network, the Canadian
Water Network (CWN), and the Stem Cell Network
(SCN) following their successful mid-term reviews.
MacDonald, Dettwiler & Associates Ltd. (MDA)
becomes a corporate member of GEOIDE – Geomatics
for Informed Decisions to "benefit from an increased
research presence," according to an official of the company
that does world-class work in advanced information solutions
for decision making.
February, 2005
Dr. Jane E. Aubin, the Scientific Co-Director
and CEO of the Canadian Arthritis Network (CAN)
wins the William F. Neumann Award for 2004
from the American Society for Bone and Mineral Research.
An AquaNet research team from the University
of New Brunswick presents findings at the American
Association for the Advancement of Science in Washington,
D.C that show a more sustainable and less polluting way of
farming fish is achieved by growing salmon, mussels, and seaweed
together.
January, 2005
Researchers with IRIS – The Institute for Robotics
and Intelligent Systems test a prototype of a water
robot that someday could monitor reefs or seabed conditions
or check conditions on offshore drilling rigs or dams.
December, 2004
The Canadian Network for Vaccines and Immunotherapeutics
(CANVAC) announces the development of a new method
to assess how well the thymus (an organ located at the base
of the neck) works and the discovery of its functional abnormality
in HIV-infected individuals – paving the way to develop
immunotherapies.
November, 2004
Industry Canada announces a $90-million,
four-year investment in the creation of the AllerGen
– Allergy, Genes and Environment Network and
the second cycle of funding for CAN,
MITACS – Mathematics of Information Technology and Complex
Systems, the Canadian Institute for Photonic
Innovations (CIPI), and GEOIDE.
CIPI leads the Putting Light to Work roundtable
discussion in Ottawa addressing the challenges of finding
and implementing strategies to move the photonics industry
forward.
October, 2004
Xenon Pharmaceuticals Inc., a Canadian
Genetic Diseases Network (CGDN) associated biotech
company, announces a partnership with the global drug giant,
Novartis Pharma AG. Under the arrangement,
Xenon will receive up to $200 million to research, develop,
and commercialize a novel treatment for obesity.
AquaNet hosts leading scientists and sector
partners in aquaculture in a Quebec City conference.
August, 2004
SCN scientists find a pancreatic cell capable
of making insulin-producing cells – a discovery that
could free people with diabetes from insulin injections.
July, 2004
The Iowa Department of Highways uses a design
concept developed by ISIS Canada – Intelligent
Sensing for Innovative Structures to construct a
steel-free bridge deck, indicative of international adoption
of Canadian technological innovation.
June, 2004
The Canadian Stroke Network (CSN) and the
Heart and Stroke Foundation of Canada join
forces to launch the Canadian Stroke Strategy
to maximize success in controlling risk factors to prevent
stroke and improving and standardizing delivery of treatment
when it does occur.
MITACS unveils a universal formula to predict
appropriate quarantine times to prevent the transmission of
infectious diseases. It could help contain the massive costs
in reining in an epidemiological disaster such as avian influenza.
CWN hosts a national symposium of researchers,
students and partners to discuss ways to improve the nation's
water quality and quantity.
May, 2004
The annual Canadian Proteomics Initiative,
sponsored by PENCE – The Protein Engineering
Network of Centres of Excellence, draws 350 participants
in Montreal. The conference is the leading national forum
for disseminating developments in proteomics and protein chemistry.
More than 200 students from 23 Canadian universities gather
at the AUTO21 Networks of Centres of Excellence
Highly Qualified People Conference in Windsor to discuss innovations
to enhance the automobile industry.
In a conference co-sponsored by CAN, leading
medical researchers, clinicians, policy makers, patients and
pharmaceutical industry representatives gather in Toronto
to identify research priorities for inflammatory joint diseases
that affects approximately 300,000 Canadians.
April, 2004
The Canadian Network for Vaccines and Immunotherapeutics
(CANVAC) begins an 18-month trial of a therapeutic
HIV vaccine – the first such clinical trial designed
and driven by academic Canadian researchers.
The Canadian Language and Literacy Research Network
distributes a calendar that translates cutting-edge
research on language and literacy development into fun, practical
activities for child-care professionals to use with children
in their care.
|
